Skip to main content

Month: March 2020

InPlay Oil Corp. Announces its 2019 Financial, Operating and Reserves Results Highlighted by a 20% Increase in Adjusted Funds Flow over 2018

CALGARY, Alberta, March 18, 2020 (GLOBE NEWSWIRE) — InPlay Oil Corp. (TSX: IPO) (OTCQX: IPOOF) (“InPlay” or the “Company”) is pleased to announce its financial and operating results for the three and twelve months ended December 31, 2019, and the results of its independent oil and gas reserves evaluation effective December 31, 2019 (the “Sproule Report”) prepared by Sproule Associates Limited (“Sproule”).  InPlay’s audited annual financial statements and notes, as well as Management’s Discussion and Analysis (“MD&A”) for the year ended December 31, 2019 will be available at “www.sedar.com” and our website at “www.inplayoil.com”.Message to Shareholders:InPlay’s strategy has always been to operate a smart, prudent, and well run junior light oil focused Company that has the ability to provide growth through its strong technical...

Continue reading

Anchiano Therapeutics Reports Year-End 2019 Financial Results

CAMBRIDGE, Mass., March 18, 2020 (GLOBE NEWSWIRE) — Anchiano Therapeutics Ltd. (Nasdaq: ANCN) (“Anchiano”), a biopharmaceutical company focused on discovery and development of novel therapies to treat cancer, today reported financial results for the year ended December 31, 2019.Key DevelopmentsEntered into an exclusive worldwide collaboration and option to license agreement on September 20, 2019 with ADT Pharmaceuticals, LLC (“ADT”) to develop novel small-molecule pan-RAS inhibitors and PDE10/β-catenin inhibitors aimed at difficult-to-treat, genetically-defined cancers, underscoring Anchiano’s focus on developing therapies with targeted approaches. Oncogenic mutations in the RAS family of genes (KRAS, HRAS, and NRAS) are present in more than 30% of all cancers. Anchiano believes that successful development of its pan-RAS-targeted...

Continue reading

NewLink Genetics Stockholders Approve Merger with Lumos Pharma

– Combined company, Lumos Pharma, Inc., to trade on Nasdaq under the stock symbol “LUMO”– Phase 2b trial expected to be initiated mid-2020 evaluating oral therapeutic candidate LUM-201 (ibutamoren) in Pediatric Growth Hormone Deficiency (PGHD)– Projected combined cash on March 31, 2020 in excess of $80 million expected to be sufficient to fund company through Phase 2b trial in PGHD data read-outAUSTIN, Texas and AMES, Iowa, March 18, 2020 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (Lumos Pharma) and NewLink Genetics Corporation (NewLink Genetics) today announced that by an overwhelming majority, NewLink Genetics’ stockholders have voted to approve the issuance of shares in connection with the merger combining NewLink Genetics with Lumos Pharma. The completion of the merger is expected to be effective in the coming days....

Continue reading

SouthGobi announces fourth quarter and full year results of 2019 on March 30, 2020

VANCOUVER, British Columbia, March 18, 2020 (GLOBE NEWSWIRE) — SouthGobi Resources Ltd. (TSX: SGQ, HK: 1878) (“SouthGobi” or the “Company”) announces that the board of directors (the “Board”) will consider and approve the financial results of the Company and its subsidiaries for the fourth quarter and the full year of 2019 on Monday, March 30, 2020. These results will be released on March 30, 2020.About SouthGobiSouthGobi, listed on the Toronto and Hong Kong stock exchanges, owns and operates its flagship Ovoot Tolgoi coal mine in Mongolia.  SouthGobi produces and sells coal to customers in China.Contact: Investor Relations Kino Fu Office: +852 2156 7030 (Hong Kong) +1 604 762 6783 (Canada) Email: Website: www.southgobi.com

Continue reading

Nordic American Tankers Ltd (NYSE: NAT) – Buy-back program

Dear Shareholders,As regards the buy-back program announced today, please note it has a scope of up to 4.5 mill NAT shares.Herbjørn HanssonChairman & CEO Matters discussed in this press release may constitute forward-looking statements.  The Private Securities Litigation Reform Act of 1995 provides safe harbor protections for forward-looking statements in order to encourage companies to provide prospective information about their business. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts.The Company desires to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection...

Continue reading

Tauriga Sciences, Inc. Files Provisional U.S. Patent Application Covering its Pharmaceutical Grade Version of Tauri-Gum

The Patent is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”NEW YORK, NY, March 18, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that it has filed a Provisional U.S. Patent Application covering its Pharmaceutical grade version of Tauri-Gum™.  This patent application, filed with the United States Patent & Trademark Office (“U.S.P.T.O.”), is titled: “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT.”  The Company’s proposed Pharmaceutical grade version of Tauri-Gum™...

Continue reading

Just Energy Receives Shareholder Meeting Requisition

TORONTO, March 18, 2020 (GLOBE NEWSWIRE) — Just Energy Group Inc. (“Just Energy”) or (the “Company”) (TSX:JE; NYSE:JE) confirms that on March 17, 2020 it received a letter from the Robert L. Snyder Trust – 2005 Stream (“Snyder”), a shareholder beneficially holding more than 5% of the common shares of Just Energy, requisitioning a Just Energy shareholder meeting.Just Energy is currently reviewing the request and will respond in due course. The Company’s previously announced strategic review remains active and Just Energy expects to announce the outcome of the review by June 30, 2020. There is no action for shareholders to take at this time. The Company will update shareholders as appropriate.Given the rapidly evolving COVID-19 pandemic currently spreading across the globe, Just Energy’s priority is the safety and well-being of its...

Continue reading

Global Arena Holding Inc. Subsidiary, Global Election Services, Successfully Completes North Dakota Democratic-NPL Presidential Primary

New York, NY, March 18, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Global Arena Holding, Inc. (the “Company”) (OTC PINK: GAHC):Global Arena Holding, Inc. (GAHC) — a growth oriented, acquisition minded company, focused on specific niche markets offering exponential growth — is pleased to announce today that its subsidiary, Global Election Services, Inc. (GES), successfully completed the North Dakota Democratic-NPL Presidential Primary election, which received a record number of voters. GES provides comprehensive technology-enabled election services to organizations such as craft and trade organizations, labor unions, co-operatives and housing organizations, associations and professional societies, universities, pension funds and credit unions, entertainment organizations and political parties.  Retained by the North Dakota...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.